Another category of cells which has therapeutic potential for ACT is NK cells and previous reports have shown IL-21 can be used to expand and improve therapeutic efficacy of CD19 CAR γδT cells or CAR NKT for cancer immunotherapy (87, 88). Here, IL21 is linked to cancer.